Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: An in vitro model

Journal of Periodontology

Volumn 82, Issue 9, 2011, Pages 1360-1366

  Mouratidou, Anastasia ^a   Karbach, Julia ^a   D'Hoedt, Bernd ^a   Al Nawas, Bilal ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anti inflammatory agents; Microbiology; Periodontitis

Indexed keywords

ACETAMIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; HETEROCYCLIC COMPOUND; LINEZOLID; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; QUINOLINE DERIVATIVE; SULBACTAM; SULTAMICILLIN;

ACTINOBACILLUS INFECTION; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ARTICLE; CAPNOCYTOPHAGA; COCULTURE; COMPARATIVE STUDY; DRUG EFFECT; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; MICROBIOLOGY; MIXED INFECTION; ORGANISMAL INTERACTION; PEPTOSTREPTOCOCCUS; PERIIMPLANTITIS; PERIODONTITIS;

ACETAMIDES; ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; AZITHROMYCIN; CAPNOCYTOPHAGA; COCULTURE TECHNIQUES; COINFECTION; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METRONIDAZOLE; MICROBIAL INTERACTIONS; MINOCYCLINE; OXAZOLIDINONES; PENICILLIN G; PEPTOSTREPTOCOCCUS; PERI-IMPLANTITIS; PERIODONTITIS; QUINOLINES; SULBACTAM;

EID: 80052985051     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.100657     Document Type: Article

References (35)

1. Leonhardt A, Renvert S, Dahlén G. Microbial findings at failing implants. Clin Oral Implants Res 1999;10: 339-345.
2. Brook I, Frazier EH. Bacteriology and beta-lactamase activity in acute exacerbation of chronic bronchitis. Int J Infect Dis 2001;5:74-77. (Pubitemid 32661022)
3. Eick S, Pfister W, Korn-Stemme S, Mägdefessel-Schmutzer U, Straube E. Pathogen and resistance spectrum in intraoral infections of the jaw-facial area with special reference to anaerobic bacteria (in German). Mund Kiefer Gesichtschir 2000;4:234-239.
4. Brook I. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents 2001;17:439-442. (Pubitemid 32492966)
5. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000;49:827-830. (Pubitemid 30666635)
6. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-493. (Pubitemid 20231076)
7. Socransky SS, Haffajee AD. Dental biofilms: Difficult therapeutic targets. Periodontol 2000 2002;28:12-55.
8. van Winkelhoff AJ, Herrera Gonzales D, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between The Netherlands and Spain. J Clin Periodontol 2000;27:79-86.
9. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002;28:106-176.
10. Bolmström A, Karlsson A, Engelhardt A, et al. Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol 2007; 45:2474-2479. (Pubitemid 47295476)
11. Citron DM, Ostovari MI, Karlsson A, Goldstein EJ. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 1991;29:2197-2203.
12. Rosenblatt JE. Can we afford to do anaerobic cultures and identification? A positive point of view. Clin Infect Dis 1997;25 (Suppl. 2):S127-S131.
13. Wüst J, Hardegger U. Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992;11:1169-1173. (Pubitemid 23069069)
14. Huang C, Liu Z, Lin N, Tu Y, Li J, Zhang D. Susceptibility of mixed infection of Ureaplasma Urealyticum and Mycoplasma Hominis to seven antimicrobial agents and comparison with that of Ureaplasma Urealyticum infection. J Huazhong Univ Sci Technolog Med Sci 2003;23:203-205. (Pubitemid 41559761)
15. Stearne LE, Kooi C, Goessens WH, Bakker-Woudenberg IA, Gyssens IC. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique. Antimicrob Agents Chemother 2001;45: 243-251. (Pubitemid 32039122)
16. DiPiro JT. Considerations for therapy of mixed infections: Focus on intraabdominal infection. Pharmacotherapy 1995;15:15S-21S.
17. Goldstein EJ. Intra-abdominal anaerobic infections: Bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clin Infect Dis 2002;35 (Suppl. 1):S106-S111.
18. Karbach J, Callaway A, Willershausen B, Wagner W, Geibel MA, Al-Nawas B. Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates. Eur J Med Res 2007;12:120-128. (Pubitemid 46564001)
19. Heilmann F. Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus. Infection 1993;21: 187-190. (Pubitemid 23197150)
20. Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev 1994;13: 65-74. (Pubitemid 24051008)
21. Brook I, Yocum P. Bacterial interference in the adenoids of otitis media-prone children. Pediatr Infect Dis J 1999;18:835-837.
22. Lepique K, Krasemann C. Influence of beta-lactamase-producers to non producers in mixed cultures. Possible implications for the treatment of chronical bronchitis and community-acquired pneumonia with penicillins (in German). Chemotherapie Journal 1997; 3:125-129. (Pubitemid 27420136)
23. Brook I. Microbiology and management of intraabdominal infections in children. Pediatr Int 2003;45: 123-129. (Pubitemid 36578927)
24. Soriano F, Ponte MC. Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures. Antimicrob Agents Chemother 1984;26:39-41. (Pubitemid 14086721)
25. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 2000 1998;17:63-76. (Pubitemid 128556018)
26. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 2002;17:267-271. (Pubitemid 35211712)
27. Mombelli A. Microbiology of the dental implant. Adv Dent Res 1993;7:202-206.
28. Molin S, Tolker-Nielsen T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol 2003;14:255-261. (Pubitemid 36782653)
29. Herrera D, van Winkelhoff AJ, Dellemijn-Kippuw N, Winkel EG, Sanz M. Beta-lactamase producing bacteria in the subgingival microflora of adult patients with periodontitis. A comparison between Spain and The Netherlands. J Clin Periodontol 2000;27:520-525.
30. Marsh PD. Dental plaque as a microbial biofilm. Caries Res 2004;38:204-211. (Pubitemid 38716211)
31. Mombelli A. In vitro models of biological responses to implant microbiological models. Adv Dent Res 1999; 13:67-72.
32. Finegold SM. Anaerobic infections in humans: An overview. Anaerobe 1995;1:3-9.
33. Alcoforado GA, Rams TE, Feik D, Slots J. Microbial aspects of failing osseointegrated dental implants inhumans (in English and French). J Parodontol 1991; 10:11-18.
34. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: A review of the literature. Clin Oral Implants Res 2002;13:1-19. (Pubitemid 41719934)
35. Quirynen M, Teughels W. Microbiologically compromised patients and impact on oral implants. Periodontol 2000 2003;33:119-126.